ÂÜÀòÂÒÂ×

Anne Osdoit is a seasoned executive with extensive experience in the medical technology industry. Anne began their career in 2005 as an Applications Specialist at Mauna Kea Technologies, where they later became the Clinical Affairs Manager and then the Director of Marketing and Clinical Affairs. In 2014, they became an Independent Board Director at FeetMe, a company that develops connected insoles and intuitive interfaces for medical applications. Anne then became the Partner at MD Start, a Europe-based medical technologies accelerator, and the President and Board Director at SafeHeal, an MD Start portfolio company. In 2017, they became the Board Director at AblaCare, an MD Start-incubated company. In 2016, they joined Sofinnova Partners as a Partner and was in charge of MD Start III medtech acceleration fund. In 2015, they became an Independent Board Director at CardioLogs, a cloud-based and Artificial Intelligence-powered ECG analysis solution. In 2020, they became the Chief Executive Officer of both Moon Surgical and Gradient Denervation Technologies.

Anne Osdoit completed their Master of Science (MS) in Biomedical/Medical Engineering at The Johns Hopkins University from 2003 to 2004. From 2000 to 2003, they obtained their MS in Engineering from \u00c9cole Polytechnique. In 2006 and 2007, they attended Pierre and Marie Curie University where they earned a DIU CESAM - Centre d'Etudes Statistiques Appliqu\u00e9es \u00e0 la M\u00e9decine in Biostatistics. In 2014, they attended The London School of Economics and Political Science (LSE) and completed a Corporate Finance & Strategy - Executive summer school in Finance, General.